LAUREN BARON: Open Payments
NPI 1023361201 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 38 payments from 9 companies in 2025. Trend: 2023 $316 · 2024 $395 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $403 |
| Vanda Pharmaceuticals Inc. | 5 | $85 |
| Amgen Inc. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| PFIZER INC. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Wegovy, FANAPT, OTEZLA, Kerendia, Ozempic, FARXIGA, PREVNAR 20, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
